Gene: RASSF10
Official Full Name: Ras association domain family member 10provided by HGNC
Gene Summary: Predicted to be involved in positive regulation of neural precursor cell proliferation and positive regulation of neurogenesis. Predicted to be located in centrosome; cytosol; and spindle pole. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14690 | RASSF10 Knockout cell line (A549) | Human | RASSF10 | 1:3~1:4 | Negative | Online Inquiry |
RASSF10 Gene Knockout Cell Lines are specifically engineered cellular models that lack expression of the RASSF10 gene, facilitating the study of its biological functions and molecular pathways. These cell lines are generated using state-of-the-art CRISPR/Cas9 technology, offering a precise and efficient method for gene disruption. By deleting the RASSF10 gene, researchers can investigate its role in various cellular processes such as apoptosis, cell cycle regulation, and tumorigenesis, providing deeper insights into the events that lead to cancer development and progression.
The primary mechanism of action involves the complete disruption of RASSF10, leading to altered cellular signaling pathways. Understanding these pathways is critical, as they can reveal potential therapeutic targets for cancer treatment. RASSF10 has been implicated in multiple malignancies, and studying its knockout variants in various cellular environments allows researchers to elucidate its contributions to tumor biology and to assess the efficacy of novel pharmacological interventions.
These cell lines are invaluable in both research and clinical contexts, particularly in cancer biology, drug discovery, and therapeutic development. Unlike conventional cell models, RASSF10 knockout cell lines provide a direct approach to study the gene's role, enabling the identification of biomarkers for cancer susceptibility and therapeutic resistance.
One of the key advantages of using RASSF10 Gene Knockout Cell Lines is their reproducibility and reliability. They eliminate off-target effects that can complicate interpretations in other gene-editing approaches, ensuring that results are robust and scientifically valid. Additionally, being readily available for research purposes accelerates the pace of discovery, providing researchers with the tools necessary to push the boundaries of current understanding in cancer research.
Our company prides itself on delivering high-quality, meticulously validated biological products tailored for scientific advancement. We are committed to supporting researchers and clinicians in their quest to unravel the complexities of biology, making our RASSF10 Gene Knockout Cell Lines a valuable addition to any laboratory dedicated to cutting-edge research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.